van de Putte LB - Search Results

1

Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies.

Schellekens GA, de Jong BA, van den Hoogen FH, van de Putte LB, van Venrooij WJ. Schellekens GA, et al. Among authors: de jong ba, van de putte lb, van venrooij wj, van den hoogen fh. J Clin Invest. 1998 Jan 1;101(1):273-81. doi: 10.1172/JCI1316. J Clin Invest. 1998. PMID: 9421490 Free PMC article.

2

The negative effect of decreasing the level of activity in coping with pain in rheumatoid arthritis: an increase in psychological distress and disease impact.

van Lankveld W, Näring G, van't Pad Bosch P, van de Putte L. van Lankveld W, et al. J Behav Med. 2000 Aug;23(4):377-91. doi: 10.1023/a:1005552901946. J Behav Med. 2000. PMID: 10984866

3

Predictors of changes in observed dexterity during one year in patients with rheumatoid arthritis.

van Lankveld WG, van 't Pad Bosch P, van de Putte L. van Lankveld WG, et al. Br J Rheumatol. 1998 Jul;37(7):733-9. doi: 10.1093/rheumatology/37.7.733. Br J Rheumatol. 1998. PMID: 9714348

4

Stress caused by rheumatoid arthritis: relation among subjective stressors of the disease, disease status, and well-being.

van Lankveld W, Näring G, van der Staak C, van 't Pad Bosch P, van de Putte L. van Lankveld W, et al. J Behav Med. 1993 Jun;16(3):309-21. doi: 10.1007/BF00844762. J Behav Med. 1993. PMID: 8350344

5

Disease-specific stressors in rheumatoid arthritis: coping and well-being.

van Lankveld W, van't Pad Bosch P, van de Putte L, Näring G, van der Staak C. van Lankveld W, et al. Br J Rheumatol. 1994 Nov;33(11):1067-73. doi: 10.1093/rheumatology/33.11.1067. Br J Rheumatol. 1994. PMID: 7981995

6

Mucocutaneous reactions to gold: a prospective study of 74 patients with rheumatoid arthritis.

van Gestel A, Koopman R, Wijnands M, van de Putte L, van Riel P. van Gestel A, et al. J Rheumatol. 1994 Oct;21(10):1814-9. J Rheumatol. 1994. PMID: 7837143

7

Circulating immune complexes and rheumatoid arthritis: the induction of immune complex formation between rheumatoid factor and IgG by polyethylene glycol.

Faaber P, van den Bersselaar LA, van de Putte L, van den Berg WB. Faaber P, et al. J Rheumatol. 1989 Oct;16(10):1304-9. J Rheumatol. 1989. PMID: 2681758

8

Longterm treatment with nonsteroidal antiinflammatory drugs in rheumatoid arthritis: a prospective drug survival study.

Wijnands M, van Riel P, van 't Hof M, Gribnau F, van de Putte L. Wijnands M, et al. J Rheumatol. 1991 Feb;18(2):184-7. J Rheumatol. 1991. PMID: 2023212 Clinical Trial.

9

Hypothalamic-pituitary-adrenal axis activity in patients with rheumatoid arthritis.

Eijsbouts AM, van den Hoogen FH, Laan RF, Hermus AR, Sweep CG, van de Putte LB. Eijsbouts AM, et al. Among authors: van de putte lb. Clin Exp Rheumatol. 2005 Sep-Oct;23(5):658-64. Clin Exp Rheumatol. 2005. PMID: 16173242

10

Efficacy and safety of the fully human anti-tumour necrosis factor alpha monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study.

van de Putte LB, Rau R, Breedveld FC, Kalden JR, Malaise MG, van Riel PL, Schattenkirchner M, Emery P, Burmester GR, Zeidler H, Moutsopoulos HM, Beck K, Kupper H. van de Putte LB, et al. Among authors: van riel pl. Ann Rheum Dis. 2003 Dec;62(12):1168-77. doi: 10.1136/ard.2003.009563. Ann Rheum Dis. 2003. PMID: 14644854 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results